Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Non-Current Assets (2023 - 2025)

Guardian Pharmacy Services' Non-Current Assets history spans 3 years, with the latest figure at $191.0 million for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 13.15% year-over-year to $191.0 million; the TTM value through Dec 2025 reached $736.6 million, changed N/A, while the annual FY2025 figure was $191.0 million, 13.15% up from the prior year.
  • Non-Current Assets for Q4 2025 was $191.0 million at Guardian Pharmacy Services, roughly flat from $191.8 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $191.8 million in Q3 2025 and bottomed at $141.6 million in Q4 2023.
  • The 3-year median for Non-Current Assets is $168.8 million (2024), against an average of $173.5 million.
  • The largest annual shift saw Non-Current Assets rose 19.26% in 2024 before it rose 13.15% in 2025.
  • A 3-year view of Non-Current Assets shows it stood at $141.6 million in 2023, then increased by 19.26% to $168.8 million in 2024, then rose by 13.15% to $191.0 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Non-Current Assets are $191.0 million (Q4 2025), $191.8 million (Q3 2025), and $185.9 million (Q2 2025).